Patient Selection Genetic Abnormalities High-risk genetic/molecular lesions (e.g., monosomy 5/del(5q), monosomy 7, high allelic ratio FLT3-ITD mutations): Proceed to hematopoietic stem cell transplantation (HSCT) after achieving first complete remission (CR1). Low-risk…
Interpretation of the American Society for Transplantation and Cellular Therapy (ASTCT) Guidelines on Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia
